Streptococcus pneumoniae induces human β-defensin-2 and -3 in human lung epithelium

Area of Science:

• Immunology
• Microbiology
• Cell Biology

Background:

• Pulmonary epithelial cells form a barrier against pathogens like Streptococcus pneumoniae.
• These cells contribute to innate immunity by producing antimicrobial peptides, including human β-defensin-2 (hBD-2) and human β-defensin-3 (hBD-3).

Purpose of the Study:

• To investigate how Streptococcus pneumoniae infection influences the expression of hBD-2 and hBD-3 in human pulmonary epithelial cells.
• To elucidate the signaling pathways involved in the induction of these antimicrobial peptides during pneumococcal pneumonia.

Main Methods:

• Human pulmonary epithelial cells were infected with Streptococcus pneumoniae.
• Toll-like receptor 2 (TLR2) involvement was assessed.
• Signaling pathways including phosphoinositide 3-kinase (PI3K)/nuclear factor kappa B (NF-κB) and c-Jun N-terminal kinase (JNK)/activator protein 1 (AP-1) were analyzed.
• Antimicrobial activity of exogenous hBD-2 and hBD-3 against S. pneumoniae was evaluated.

Main Results:

• Pneumococci infection induced the expression of hBD-2 and hBD-3 in pulmonary epithelial cells.
• Toll-like receptor 2 (TLR2) was essential for the induction of both hBD-2 and hBD-3.
• hBD-2 release was regulated by the PI3K/NF-κB pathway.
• hBD-3 expression was mediated by the JNK/AP-1 pathway.
• Both hBD-2 and hBD-3 demonstrated significant antimicrobial activity against S. pneumoniae.

Conclusions:

• The expression of hBD-2 and hBD-3 is differentially regulated in response to Streptococcus pneumoniae infection.
• TLR2 plays a critical role in initiating the innate immune response via these antimicrobial peptides.
• Understanding these distinct pathways may offer insights into therapeutic strategies for pneumococcal pneumonia.